Long-term follow-up from the ORATORIO trial of ocrelizumab for primary progressive multiple sclerosis: a post-hoc analysis from the ongoing open-label extension of the randomised, placebo-controlled, phase 3 trial
| Image |  |
|---|---|
| Description | scientific article published on 29 October 2020 |
| Author/s |
author: Xavier Montalban Marianna Manfrini Stanislas Hubeaux Annette Sauter Ludwig Kappos Stephen L. Hauser |
| Publication date | October 29, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |